Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy-Reference-Cited by-同舟云学术

Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy

Published:1998-09 Issue:3 Volume:15 Page:174-182
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

ten Bokkel Huinink WW,de Swart CAM,van Toorn DW,Morack G,Breed WPM,Hillen HFP,van der Hoeven JJM,Reed NS,Fairlamb DJ,Chan SYT,Godfrey KA,Kristensen GB,van Tinteren H,Ehmer B

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02821936.pdf

Reference21 articles.

1. Abels R. Erythropoietin for anaemia in cancer patients.Eur J Cancer 1993;29A: 2–8.

2. Kaye SBet al. Randomized study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer.Lancet 1992;340: 329–333.

3. Ludwig Het al. Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors.Ann Oncol 1993;4: 161–167.

4. Bush RS. The significance of anemia in clinical radiation therapy.Int J Radiat Oncol Biol Phys 1986;12: 2047–2050.

5. Girinski Tet al. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients.Int J Radiat Oncol Biol Phys 1989;16: 37–42.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2022-06-20

2. Recombinant blood products and therapeutic enzymes: An update;The Future of Pharmaceutical Product Development and Research;2020

3. Indications for and complications of transfusion and the management of gynecologic malignancies;Gynecologic Oncology;2017-08

4. Erythropoiesis-stimulating agents in gynecological malignancies: A study-level meta-analysis;Critical Reviews in Oncology/Hematology;2016-03

5. The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model;Health Technology Assessment;2016-02